TGF-β signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 31, 2008, Pages 10865-10870

  Laouar, Yasmina ^a,c   Town, Terrence ^a,d   Jeng, David ^a   Tran, Elise ^a   Wan, Yisong ^a   Kuchroo, Vijay K ^b   Flavell, Richard A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Brain; CNS; Spinal cord

Indexed keywords

CD11 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEATH; DENDRITIC CELL; IMMUNIZATION; INFLAMMATION; INNATE IMMUNITY; LOCOMOTION; MICROGLIA; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

ADOPTIVE TRANSFER; ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GLYCOPROTEINS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

MUS; MUS MUSCULUS;

EID: 49449116101     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0805058105     Document Type: Article

References (32)

1. Steinman L, Zamvil SS (2005) Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol 26:565-571.
2. Zamvil SS, et al. (1986) T cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324:258-260.
3. Tuohy VK, et al. (1989) Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol 142:1523-1527.
4. Mendel I, Kerlero de Rosbo N, Ben-Nun A (1995) A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur J Immunol 25:1951-1959.
5. Johns LD, Flanders KC, Ranges GE, Sriram S (1991) Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J Immunol 147:1792-1796.
6. Racke MK, et al. (1991) Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J Immunol 146:3012-3017.
7. Kuruvilla AP, et al. (1991) Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 88:2918-2921.
8. Racke MK, et al. (1992) Evidence of endogenous regulatory function of transforming growth factor-β1 in experimental allergic encephalomyelitis. Intl immunol 4:615-620.
9. Issazadeh S, et al. (1995) Interferon γ, interleukin 4, and transforming growth factor β in experimental autoimmune encephalomyelitis in Lewis rats: Dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J Neurosci Res 40:579-590.
10. Johns LD, Sriram S (1993) Experimental allergic encephalomyelitis: Neutralizing antibody to TGF-β1 enhances the clinical severity of the disease. J Neuroimmunol 47:1-7.
11. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87:159-170.
12. Bai XF, et al. (1997) Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-β mRNA. J Neuroimmunol 80:65-75.
13. Laouar Y, Sutterwala FS, Gorelik L, Flavell RA (2005) Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γ. Nat Immunol 6:600-607.
14. Yamamoto A, Lucas JJ, Hen R (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101:57-66.
15. Ransohoff RM, Kivisakk P, Kidd G (2003) Three or more routes for leukocyte migration into the central nervous system. Nat Rev 3:569-581.
16. Juedes AE, Ruddle NH (2001) Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J Immunol 166:5168-5175.
17. Aloisi F, Ria F, Adorini L (2000) Regulation of T cell responses by CNS antigen-presenting cells: Different roles for microglia and astrocytes. Immunol today 21:141-147.
18. Tran EH, Prince EN, Owens T (2000) IFN-γ shapes immune invasion of the central nervous system via regulation of chemokines. J Immunol 164:2759-2768.
19. Komiyama Y, et al. (2006) IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177:566-573.
20. Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR (2007) Autoimmune inflammation from the Th17 perspective. Autoimmunity Rev 6:169-175.
21. Cao X, et al. (1995) Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 2:223-238.
22. Vosshenrich CA, et al. (2005) Roles for common cytokine receptor γ-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol 174:1213-1221.
23. Rinner WA, et al. (1995) Resident microglia and hematogenous macrophages as phagocytes in adoptively transferred experimental autoimmune encephalomyelitis: An investigation using rat radiation bone marrow chimeras. Glia 14:257-266.
24. Becher B, et al. (2001) The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J Exp Med 193:967-974.
25. Bettelli E, et al. (2003) Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 197:1073-1081.
26. + T(H)-17 cells in relapsing EAE. Nat Immunol 8:172-180.
27. Marie P, et al. (1884) Multiple Sclerosis and infectious diseases (Sclerose en plaques et maladies infectieuses). Prog Med 287-289.
28. Keegan BM, Noseworthy JH (2002) Multiple sclerosis. Annu Rev Med 53:285-302.
29. Sospedra M, Pinilla C, Martin R (2003) Use of combinatorial peptide libraries for T cell epitope mapping. Methods 29:236-247.
30. Fujinami RS, Oldstone MB (1989) Molecular mimicry as a mechanism for virus-induced autoimmunity. Immuol Res 8:3-15.
31. Fujinami RS, Oldstone MB (1985) Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity. Science 230:1043-1045.
32. Gran B, et al. (1999) Molecular mimicry and multiple sclerosis: Degenerate T cell recognition and the induction of autoimmunity. Ann Neurol 45:559-567.